APA

Willhauck M. J., Sharif Samani B. R., Klutz K., Cengic N., Wolf I., Mohr L., Geissler M., Senekowitsch-Schmidtke R., Göke B., Morris J. C. & Spitzweg C. (20080411). Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma. : Gene therapy.

Chicago

Willhauck M J, Sharif Samani B R, Klutz K, Cengic N, Wolf I, Mohr L, Geissler M, Senekowitsch-Schmidtke R, Göke B, Morris J C and Spitzweg C. 20080411. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma. : Gene therapy.

Harvard

Willhauck M. J., Sharif Samani B. R., Klutz K., Cengic N., Wolf I., Mohr L., Geissler M., Senekowitsch-Schmidtke R., Göke B., Morris J. C. and Spitzweg C. (20080411). Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma. : Gene therapy.

MLA

Willhauck M J, Sharif Samani B R, Klutz K, Cengic N, Wolf I, Mohr L, Geissler M, Senekowitsch-Schmidtke R, Göke B, Morris J C and Spitzweg C. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma. : Gene therapy. 20080411.